Efficacy and safety of 1,000 mg effervescent aspirin: individual patient data meta-analysis of three trials in migraine headache and migraine accompanying symptoms.

Efficacy and safety of 1,000 mg effervescent aspirin: individual patient data meta-analysis of three trials in migraine headache and migraine accompanying symptoms. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Efficacy and safety of 1,000 mg effervescent aspirin: individual patient data meta-analysis of three trials in migraine headache and migraine accompanying symptoms. Abstract Text:

Christian Lampl,M Voelker,H C Diener,Christian Lampl,M Voelker,H C Diener,

Migraine is often associated with health consequences including impaired quality of life, and the cost of treating migraine headaches places a significant financial burden on patients who suffer from migraines. Nonsteroidal anti-inflammatory drugs (NSAIDs) and triptans are commonly used for the treatment of acute migraine attacks. Aspirin is widely accepted as a treatment option for migraine pain relief and could provide an alternative not only for treatment of moderate migraine attacks, but also for severe migraine attacks. The efficacy and safety of 1,000 mg effervescent aspirin (eASA) was evaluated in comparison to 50 mg sumatriptan and placebo in an individual patient data meta-analysis of three randomized, placebo-controlled, single- dose migraine trials. Pain-relief at 2 h, pain-free at 2 h and sustained pain-free up to 24 h were calculated. For eASA, the response rates were 51.5 % (95 % CI: 46.6-56.5 %), 27.1 % (95 % CI: 22.6-31.4 %), and 23.5 % (95 % CI: 19.3-27.7 %). For sumatriptan, the response rates were 46.6 % (95% CI: 40.0-53.2 %), 29% (95 % CI: 23.0-34.9 %), and 22.2 % (95 % CI: 16.7-27.6 %). The corresponding rates for placebo were 33.9 % (95% CI: 29.1-38.6 %), 15.1 % (95 % CI: 11.5-18.7 %), and 14.6 % (95 % CI: 11.0-18.1 %). The treatment effect of eASA and sumatriptan were significantly different from placebo (p < 0.001), but differences between eASA and sumatriptan were not significant. The remission of accompanying symptoms and the subgroup analyses of patients with moderate or severe migraine pain at baseline revealed no significant differences between eASA and sumatriptan. Safety was evaluated based on the frequency of reported adverse events, and treatment with eASA was associated with lower incidence of adverse events than was with sumatriptan. This individual patient data meta-analysis provided evidence that eASA 1,000 mg is as effective as sumatriptan 50mg for the treatment of acute migraine attacks and has a better side effect profile. This is also true for patients with moderate as well as severe headache at baseline. Patients therefore should be advised to use eASA first for migraine attacks and use a triptan in case of no response.

Efficacy and safety of 1,000 mg effervescent aspirin: individual patient data meta-analysis of three trials in migraine headache and migraine accompanying symptoms. Publishing Authors By Initials

C Lampl,M Voelker,HC Diener,C Lampl,M Voelker,HC Diener,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Efficacy and safety of 1,000 mg effervescent aspirin: individual patient data meta-analysis of three trials in migraine headache and migraine accompanying symptoms. Journal Published:

PUBLICATION TYPE: Meta-Analysis

Journal: Journal of neurology

VOLUME: 254

Page Numbers: 705-12

Journal Abbreviation: J. Neurol.

ISSN: 0340-5354

DAY: 10

MONTH: 04

YEAR: 2007

Efficacy and safety of 1,000 mg effervescent aspirin: individual patient data meta-analysis of three trials in migraine headache and migraine accompanying symptoms. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 423161

Efficacy and safety of 1,000 mg effervescent aspirin: individual patient data meta-analysis of three trials in migraine headache and migraine accompanying symptoms. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Efficacy and safety of 1,000 mg effervescent aspirin: individual patient data meta-analysis of three trials in migraine headache and migraine accompanying symptoms. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Efficacy and safety of 1,000 mg effervescent aspirin: individual patient data meta-analysis of three trials in migraine headache and migraine accompanying symptoms.

AFFILIATION: Dept. of Neurology, Pain and Headache Center, Krankenhaus der Barmherzigen Schwestern, Seilerstätte 4, A-4010 Linz, Austria.

Country: Germany

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: J Neurol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Efficacy and safety of 1,000 mg effervescent aspirin: individual patient data meta-analysis of three trials in migraine headache and migraine accompanying symptoms Related Publications

• A personal view of the classification and definition of drug dependence headache.
• Antiplatelet agents and randomized trials.
• Ca( 2+ )-induced cl (-) efflux at rat distal colonic epithelium.
• Clopidogrel versus aspirin in patients with atherothrombosis: CAPRIE-based calculation of cost-effectiveness for Germany.
• Cortical activation in hemianopia after stroke.
• Effect of active treatment is lower when using placebo control in clinical trials on acute therapy of migraine.
• Effect of carbon dioxide, temperature, and relative humidity on production of aflatoxin in peanuts.
• Efficacy and safety of 1,000 mg effervescent aspirin: individual patient data meta-analysis of three trials in migraine headache and migraine accompanying symptoms.
• How can PET scans help us understand headache mechanisms?
• Low-dose aspirin for migraine prophylaxis in women.
• Low-dose ibuprofen in self-medication of mild to moderate headache: a comparison with acetylsalicylic acid and placebo.
• Placebo in headache trials.
• RPR100893, a substance-P antagonist, is not effective in the treatment of migraine attacks.
• Saccade induced cortical activation in patients with post-stroke visual field defects.
• Se02 the validity of an integrated clinical simulator for learning laparoscopic appendicectomy.
• Stimulation of voltage-dependent Ca2+ channels by NO at rat myenteric neurons.
• Sumatriptan in the treatment of cluster headache.
• Sumatriptan: vasoactive effect on human dural vessels, demonstrated by subselective angiography.
• Systemic Risk Score Evaluation in Ischemic Stroke Patients (SCALA) : A prospective cross sectional study in 85 German stroke units.
• Trigeminal autonomic cephalalgias: a case of post-traumatic SUNCT syndrome?
• Use of almotriptan in triptan-experienced and triptan-naïve patients.
• [Abortion after the 12th completed pregnancy week. Report of experience of a specialist commission]
• [Development of a screening tool for migraine prophylaxis]
• [Incidence of hidden iron deficiency in women, especially in pregnancy and puerperium.]
• [Monitoring stroke units: management, outcome, efficiency]
• [On the applicability of vaginal cytology in the determination of delivery term and in the recognition of prolonged pregnancy]
• [Pathogenesis of anemia in myomas.]
• [Results in the management of pregnancies involving risk factors]
• [Serologic toxoplasmosis control in pregnancy using enzyme immunoassay (EIA). 1st experiences]
• [The change of cervical state during pregnancy (author's transl)]